ENT Devices: By Type (Surgical Devices, Co2 Lasers, Image-Guided Surgery Systems, Diagnostic Devices, Hearing Aids and Hearing Implants), By End user (Home Use, Hospitals and Ambulatory Settings and ENT Clinics), And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031

March 2023 | 346 pages | ID: E05733E9A015EN
Fatpos Global

Abstracts

Market Overview

The report, ENT Devices- Analysis of Market Size, Share & Trends for 2014 - 2022 and Forecasts to 2032, was published by Fatpos Global and is expected to reach Market Value. Fatpos Global conducted a study. The report, in order to provide a thorough understanding of the global market, emphasises the detailed understanding of some key factors, such as size, share, sales, forecast trends, supply, production, demands, industry, and CAGR.

The ENT Devices grew from USD 19.96 Billion in 2022 to USD 28.12 Billion by 3032, exhibiting a CAGR of 6.4% during the forecast period.

Key Companies Profiled

• Atos Medical AB

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Cochlear Limited
• Olympus Corporation
• Rion Co. Ltd
• Siemens Healthcare
• Hoya Corporation
• Medtronic PLC
• Olympus Corporation
• Rion Co. Ltd
• Siemens Healthcare
• Other Prominent Players

ENT Devices: Segmentation

• By Type
• Surgical Devices
• Co2 Lasers
• Image-Guided Surgery Systems
• Diagnostic Devices
• Hearing Aids
• Hearing Implants
• By End user
• Home Use
• Hospitals and Ambulatory Settings
• ENT Clinics
• ENT Devices Dynamics
• ENT Devices Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints
• ENT Devices Dynamics
• Size Supply and Demand ENT Devices
• Current Issues/Trends/Challenges
• Companies and Competition Market Drivers and Restraints Involved in the Market Value Chain
• The report sheds light on various aspects and provides answers to pertinent market questions. Among the most important are:
• Pre- and post-business impact analysis of COVID-19
• A thorough examination of the parent market
• Market dynamics in the industry are changing.
• Market segmentation in depth
• What is the ENT Devices expansion?
• Which segment had the highest ENT Devices share?
• Who are the main characters in ENT Devices?
• Historical, current, and projected market volumes and values
• Trends and developments in the industry recently
• The competitive environment
• Key players' strategies and products on offer
• Potential and niche segments, as well as geographical regions with promising growth prospects
• A balanced assessment of market performance
• Information that markets participants must have in order to maintain and expand their market footprint.

Note: Although Fatpos Global has taken great care to ensure the highest levels of accuracy in its studies, it might take some time for significant changes to the market or a particular vendor to be reflected in the research.

Contents

1 EXECUTIVE SUMMARY

2 GLOBAL ENT DEVICES

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3 RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4 AVERAGE PRICING ANALYSIS

5 MACRO-ECONOMIC INDICATORS

6 MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7 CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9 RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10 GLOBAL ENT DEVICES ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11 GLOBAL ENT DEVICES

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12 GLOBAL ONCOLOGY PHARMACEUTICALS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
  12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Indication: Market Share (2020-2030F)
  12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
  12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13 COMPANY PROFILE

Atos Medical AB
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Cochlear Limited
Olympus Corporation
Rion Co. Ltd
Siemens Healthcare
Hoya Corporation
Medtronic PLC
Olympus Corporation
Rion Co. Ltd
Siemens Healthcare
Other Prominent Players

14 CONSULTANT RECOMMENDATION

**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.